| Officer | In this role | Source |
|---|---|---|
|
Ilan Sobel
Chief Executive Officer
|
Since 2020
6 years
|
|
|
Bar Dichter
Chief Financial Officer
|
Since 2024
2 years
|
|
|
Zaki Rakib
Also a director
President; Chairman
|
Not stated | |
|
Ilana Belzer
Chief Operating Officer
|
Since 2023
3 years
|
|
|
Yoheved (Yochi) Hagay
Chief Technology Officer
|
Since 2018
8 years
|
|
|
David Ryan
Secretary; Vice-President, Investor Relations
|
Not stated | |
|
Malkit Azachi
Vice-President, Research and Development
|
Since 2024
2 years
|
|
|
Michal Sapir
Vice-President, Regulatory Affairs
|
Since 2024
2 years
|
|
|
Jared Turner
Vice-President, D2C Products Business Unit
|
Since 2024
2 years
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. BIOHARVEST SCIENCES INC. has not filed one with the SEC.
Loading...